Clinical trial
Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of…
NCT00138112 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00138112 |
|---|---|
| Title | Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation |
| Official title | Randomized Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Early Viridans Streptococcal Sepsis After Hematopoietic Cell Transplantation |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Streptococcal Sepsis, Hematologic Malignancies |
| Intervention type | Drug |
| Interventions | Empirical Vancomycin, Prophylactic Vancomycin |
| Enrollment | 126 |
| Start date | Nov 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Aug 30, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: